HIV Citations List: February, 2016
Literature Citations
1. Long Lasting Control of Viral Rebound with a New Drug ABX464 Targeting Rev - Mediated Viral RNA Biogenesis. Campos, N., R. Myburgh, A. Garcel, A. Vautrin, L. Lapasset, E.S. Nadal, F. Mahuteau-Betzer, R. Najman, P. Fornarelli, K. Tantale, E. Basyuk, M. Seveno, J.P. Venables, B. Pau, E. Bertrand, M.A. Wainberg, R.F. Speck, D. Scherrer, and J. Tazi. Retrovirology, 2015. 12( 30): 15pp. PMID[25889234]. PMCID[PMC4422473].
[PubMed].HIV_02_2016.
2. Design, Synthesis and In-vitro Evaluation of Novel Tetrahydroquinoline Carbamates as HIV-1 RT Inhibitor and their Antifungal Activity. Chander, S., P. Ashok, Y.T. Zheng, P. Wang, K.S. Raja, A. Taneja, and S. Murugesan. Bioorganic Chemistry, 2016. 64: p. 66-73. PMID[26717022].
[PubMed].HIV_02_2016.
3. Design, Synthesis, and Biological Evaluation of Novel 2-(Pyridin-3-yloxy)acetamide Derivatives as Potential anti-HIV-1 Agents. Huang, B., X. Li, P. Zhan, E. De Clercq, D. Daelemans, C. Pannecouque, and X. Liu. Chemical Biology & Drug Design, 2016. 87(2): p. 283-289. PMID[26347922].
[PubMed].HIV_02_2016.
4. Novel Diarylpyrimidines and Diaryltriazines as Potent HIV-1 NNRTIs with Dramatically Improved Solubility: A Patent Evaluation of US20140378443A1. Huang, B., D. Kang, J. Yang, P. Zhan, and X. Liu. Expert Opinion on Therapeutic Patents, 2016. 26(2): p. 281-289. PMID[26559996].
[PubMed].HIV_02_2016.
5. Marine Pyridoacridine Alkaloids: Biosynthesis and Biological Activities. Ibrahim, S.R.M. and G.A. Mohamed. Chemistry & Biodiversity, 2016. 13(1): p. 37-47. PMID[26765351].
[PubMed].HIV_02_2016.
6. The Antiviral Compound BIT225 Inhibits HIV-1 Replication in Myeloid Dendritic Cells. Khoury, G., G. Ewart, C. Luscombe, M. Miller, and J. Wilkinson. AIDS Research and Therapy, 2016. 13(7): 5pp. PMID[26858771].
[PubMed].HIV_02_2016.
7. Molecular Modeling, Synthesis, and anti-HIV Activity of Novel Isoindolinedione Analogues as Potent Non-Nucleoside Reverse Transcriptase Inhibitors. Kumari, G. and R.K. Singh. Chemical Biology & Drug Design, 2016. 87(2): p. 200-212. PMID[26212217].
[PubMed].HIV_02_2016.
8. Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice. Mediouni, S., J. Jablonski, J.J. Paris, M.A. Clementz, S. Thenin-Houssier, J.P. McLaughlin, and S.T. Valente. Current HIV research, 2015. 13(1): p. 64-79. PMID[25613133]. PMCID[PMC4416414].
[PubMed]. HIV_02_2016.
9. A Minimally Cytotoxic CD4 Mimic as an HIV Entry Inhibitor. Mizuguchi, T., S. Harada, T. Miura, N. Ohashi, T. Narumi, H. Mori, Y. Irahara, Y. Yamada, W. Nomura, S. Matsushita, K. Yoshimura, and H. Tamamura. Bioorganic & Medicinal Chemistry Letters, 2016. 26(2): p. 397-400. PMID[26706175].
[PubMed].HIV_02_2016.
10. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. Mousseau, G., C.F. Kessing, R. Fromentin, L. Trautmann, N. Chomont, and S.T. Valente. MBio, 2015. 6(4): p. e00465. PMID[26152583].
[PubMed].HIV_02_2016.
11. Exploring the Role of the alpha-Carboxyphosphonate Moiety in the HIV-RT Activity of alpha-Carboxy nucleoside phosphonates. Mullins, N.D., N.M. Maguire, A. Ford, K. Das, E. Arnold, J. Balzarini, and A.R. Maguire. Organic & Biomolecular Chemistry, 2016. 14(8): p. 2454-2465. PMID[26813581]. PMCID[PMC475589].
[PubMed].HIV_02_2016.
12. Alkaloids from the Sponge Stylissa carteri Present Prospective Scaffolds for the Inhibition of Human Immunodeficiency Virus 1 (HIV-1). O'Rourke, A., S. Kremb, T.M. Bader, M. Helfer, P. Schmitt-Kopplin, W.H. Gerwick, R. Brack-Werner, and C.R. Voolstra. Marine Drugs, 2016. 14(2): 10pp. PMID[26861355].
[PubMed].HIV_02_2016.
13. A New Vinyl Selenone-based Domino Approach to Spirocyclopropyl oxindoles Endowed with anti-HIV RT Activity. Palomba, M., L. Rossi, L. Sancineto, E. Tramontano, A. Corona, L. Bagnoli, C. Santi, C. Pannecouque, O. Tabarrini, and F. Marini. Organic & Biomolecular Chemistry, 2016. 14(6): p. 2015-2024. PMID[26754878].
[PubMed].HIV_02_2016.
14. Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization, and Antiviral Activity. Pena-Gonzalez, C.E., P. Garcia-Broncano, M.F. Ottaviani, M. Cangiotti, A. Fattori, M. Hierro-Oliva, M.L. Gonzalez-Martin, J. Perez-Serrano, R. Gomez, M.A. Munoz-Fernandez, J. Sanchez-Nieves, and F.J. de la Mata. Chemistry, 2016. 22(9): p. 2987-2999. PMID[26875938].
[PubMed].HIV_02_2016.
15. Correction to Discovery of 2-Pyridinone aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors. Raheem, I.T., A.M. Walji, D. Klein, J.M. Sanders, D.A. Powell, P. Abeywickrema, G. Barbe, A. Bennet, K. Childers, M. Christensen, S.D. Clas, D. Dubost, M. Embrey, J. Grobler, M.J. Hafey, T.J. Hartingh, D.J. Hazuda, J.T. Kuethe, J.M. Dunn, M.D. Miller, K.P. Moore, A. Nolting, N. Pajkovic, S. Patel, Z.H. Peng, V. Rada, P. Rearden, J.D. Schreier, J. Sisko, T.G. Steele, J.F. Truchon, J. Wai, M. Xu, and P.J. Coleman. Journal of Medicinal Chemistry, 2016. 59(1): p. 486-486. PMID[26709958].
[PubMed].HIV_02_2016.
16. Alkaloids from Croton echinocarpus Baill.: Anti-HIV Potential. Ravanelli, N., K.P. Santos, L.B. Motta, J.H.G. Lago, and C.M. Furlan. South African Journal of Botany, 2016. 102: p. 153-156. ISI[000368959100021].
[WOS].HIV_02_2016.
17. Potent in Vitro Antiviral Activity of Cistus incanus Extract against HIV and Filoviruses Targets Viral Envelope Proteins. Rebensburg, S., M. Helfer, M. Schneider, H. Koppensteiner, J. Eberle, M. Schindler, L. Gurtler, and R. Brack-Werner. Scientific Reports, 2016. 6(20394): 15pp. PMID[26833261]. PMCID[PMC4735868].
[PubMed].HIV_02_2016.
18. Structural Analogs of Umifenovir 2*. The Synthesis and AntiHIV Activity Study of New Regioisomeric (trans-2-Phenylcyclopropyl)-1H-indole Derivatives. Schols, D., E.A. Ruchko, S.N. Lavrenov, V.V. Kachala, M.B. Nawrozkij, and A.S. Babushkin. Chemistry of Heterocyclic Compounds, 2015. 51(11-12): p. 978-983. ISI[000369005200004].
[WOS].HIV_02_2016.
19. Rilpivirine Analogs Potently Inhibit Drug-Resistant HIV-1 Mutants. Smith, S.J., G.T. Pauly, A. Akram, K. Melody, G. Rai, D.J. Maloney, Z. Ambrose, C.J. Thomas, J.T. Schneider, and S.H. Hughes. Retrovirology, 2016. 13(11): 13pp. PMID[26880034]. PMCID[PMC4754833].
[PubMed].HIV_02_2016.
20. Pyridoxine hydroxamic acids as Novel HIV-Integrase Inhibitors. Stranix, B.R., J.J. Wu, G. Milot, F. Beaulieu, J.E. Bouchard, K. Gouveia, A. Forte, S. Garde, Z. Wang, J.F. Mouscadet, O. Delelis, and Y. Xiao. Bioorganic & Medicinal Chemistry Letters, 2016. 26(4): p. 1233-1236. PMID[26826732]. [PubMed]. HIV_02_2016.
21. Identification of a Small Molecule HIV-1 Inhibitor that Targets the Capsid Hexamer. Xu, J.P., J.D. Branson, R. Lawrence, and S. Cocklin. Bioorganic & Medicinal Chemistry Letters, 2016. 26(3): p. 824-828. PMID[26747394]. PMCID[PMC4728034].
[PubMed]. HIV_02_2016.
22. Design, Synthesis and anti-HIV Evaluation of Novel Diarylpyridine Derivatives Targeting the Entrance Channel of NNRTI Binding Pocket. Yang, J., W. Chen, D. Kang, X. Lu, X. Li, Z. Liu, B. Huang, D. Daelemans, C. Pannecouque, E. De Clercq, P. Zhan, and X. Liu. European Journal of Medicinal Chemistry, 2016. 109: p. 294-304. PMID[26802545].
[PubMed]. HIV_02_2016.
23. 8-O-4'-Neolignans from the Stem Bark of Illicium difengpi and their anti-HIV-1 Activities. Yang, Y.C., Y. Qin, Y.L. Meng, C.F. Xia, X.M. Gao, and Q.F. Hu. Chemistry of Natural Compounds, 2016. 52(1): p. 43-47. ISI[000368699400008].
[WOS].HIV_02_2016.
Patent Citations
24. Targeted Deubiquitinating Enzyme Fusion Proteins Disrupting Human Immunodeficiency Virus Maturation and Budding. Bouamr, F. and P. Sette. Patent. 2016. 2015-US42492 2016018921: 95pp.
[Patent]. HIV_02_2016.
25. Application of Stellera chamaejasme Toxin Diterpene in Preparation of anti-AIDS Agent. Chen, D., M. Yan, Y. Lu, and G. Li. Patent. 2016. 2014-10309142 105287497: 8pp.
[Patent]. HIV_02_2016.
26. Preparation of Pyrrolo[2,3-b]pyridine-2-Carboxamide Compounds as HIV-1 Integrase Inhibitors. Hu, L., L. Ju, Z. Mao, Z. Li, and C. Zeng. Patent. 2016. 2015-10873837 105294688: 22pp.
[Patent]. HIV_02_2016.
27. Isoindolinone Derivatives Useful as Antiviral Agents and Their Preparation. Johns, B.A., E.J. Velthuisen, and J.G. Weatherhead. Patent. 2016. 2015-IB55489 2016012930: 26pp.
[Patent]. HIV_02_2016.
28. Preparation of 1H-Indene Compounds as CD4-Mimetics Inhibiting HIV-1 Entry for the Treatment of HIV Infection. Smith, A.B., III, J. Sodroski, N. Madani, and B. Melillo. Patent. 2016. 2015-US44998 2016025681: 92pp.
[Patent]. HIV_02_2016.
29. Preparation of Polycyclic Pyridone Derivatives with HIV Integrase Inhibitory Effect, and AIDS Treatment Using Them. Yoshinaga, T. and K. Nodu. Patent. 2016. 2015-JP73487 2016027879: 179pp.
[Patent]. HIV_02_2016.